BF Biosciences is evolving into one of Pakistan’s most promising long-term pharma compounders, driven by rapid growth in specialty injectables and the early leadership it has built in locally manufactured GLP-1 products. The company’s recent launch of Zeptide® (tirzepatide) and continued scale-up of semaglutide-based diabetes and obesity products gives it exposure to one of the fastest-growing therapy segments globally.Read more